Ampyra and Breastfeeding
The full risks of breastfeeding while using Ampyra (dalfampridine) are currently unknown, as no studies have been done on this topic. The manufacturer of the drug advises women to avoid this medication while nursing a child. Before taking Ampyra, nursing women should consult their healthcare providers about the benefits and risks in their particular situation.
Is Ampyra Safe While Breastfeeding?At this time, it is unknown if Ampyra™ (dalfampridine) passes through breast milk. The manufacturer recommends that women should not take Ampyra while breastfeeding. If you are nursing a child, talk with your healthcare provider before taking this medication.
More Information on Breastfeeding and AmpyraNo research has been done to see if Ampyra passes through breast milk. Although this lack of information is certainly frustrating, it is important to understand that studies of medications are rarely done in breastfeeding women, as this would usually expose an infant (who will not directly benefit from the medication) to possible risks.
Talking With Your Healthcare ProviderYou should discuss breastfeeding and Ampyra with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.